ストックスクリーナーアプリを入手
35.07
0.45%
-0.16
アフターアワーズ：
35.17
0.10
+0.29%
前日終値:
$35.23
開ける：
$35.17
24時間の取引高:
478.68K
Relative Volume:
0.44
時価総額：
$1.72B
収益：
$96.21M
当期純損益:
$-12.13M
株価収益率:
-112.04
EPS:
-0.313
ネットキャッシュフロー:
$10.64M
1週間 パフォーマンス:
+1.18%
1か月 パフォーマンス:
+22.41%
6か月 パフォーマンス:
+57.76%
1年 パフォーマンス:
+38.51%
1日の値動き範囲:
$34.81
$35.22
1週間の範囲:
$33.75
$35.35
52週間の値動き範囲:
$17.86
$35.35
Biolife Solutions Inc Stock (BLFS) Company Profile
名前
Biolife Solutions Inc
セクター
電話
(425) 401-1400
住所
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, RMD, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
35.07 | 1.71B | 96.21M | -12.13M | 10.64M | -0.313 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-22 | 再開されました | Stephens | Overweight |
| 2024-09-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-04-04 | 開始されました | Jefferies | Buy |
| 2023-07-11 | 開始されました | Craig Hallum | Buy |
| 2022-04-25 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-10-19 | 開始されました | B. Riley Securities | Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-05-14 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2021-03-23 | アップグレード | The Benchmark Company | Hold → Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-09-18 | 開始されました | Cowen | Outperform |
| 2020-08-11 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2020-07-08 | 繰り返されました | Maxim Group | Buy |
| 2020-02-24 | 開始されました | Lake Street | Buy |
| 2020-02-19 | 開始されました | The Benchmark Company | Buy |
| 2020-02-06 | 再開されました | B. Riley FBR | Buy |
| 2020-01-08 | 開始されました | Stephens | Overweight |
| 2019-11-21 | 開始されました | Oppenheimer | Outperform |
| 2019-07-22 | 開始されました | H.C. Wainwright | Buy |
| 2017-11-10 | 繰り返されました | Maxim Group | Buy |
| 2017-09-19 | 繰り返されました | Maxim Group | Buy |
| 2017-07-05 | アップグレード | Janney | Neutral → Buy |
| 2017-03-10 | 繰り返されました | Maxim Group | Buy |
| 2017-01-19 | 開始されました | Maxim Group | Buy |
すべてを表示
Biolife Solutions Inc (BLFS) 最新ニュース
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
BioLife Solutions, Inc. (BLFS) Stock Forecasts - Yahoo! Finance Canada
BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating a High Forward P/E Amid Robust Growth in the Healthcare Sector - DirectorsTalk Interviews
BioLife Solutions (NASDAQ:BLFS) Hits New 12-Month HighTime to Buy? - MarketBeat
BioLife Solutions Cut to Hold From Buy by Benchmark - Moomoo
Why BioLife Solutions (BLFS) Is Up 7.8% After Swinging To Q2 Profitability And What's Next - simplywall.st
BioLife Solutions (BLFS) Stock Price Ignores A Sharp Turn To Profit - simplywall.st
BioLife Solutions Inc (BLFS) Stock News Today - TradingKey
Royal Bank of Canada Purchases 66,010 Shares of BioLife Solutions, Inc. $BLFS - MarketBeat
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 ProfitWhat's Changed - Yahoo Finance
Is BioLife Solutions Inc (BLFS) Overvalued After Q2 Earnings Bea - GuruFocus
BioLife Solutions (NASDAQ:BLFS) Posts Earnings Results, Beats Estimates By $0.88 EPS - MarketBeat
BLFS Technical Analysis & Stock Price Forecast - Intellectia AI
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
BioLife Solutions, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
BioLife Solutions 2026: Revenue $28.47M, EPS $0.91— 10-Q Summary - TradingView
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, vs. FactSet Est of $27.8M - marketscreener.com
BioLife Solutions (NASDAQ: BLFS) plans cash-stock merger with Repligen - Stock Titan
BioLife Solutions reports Q2 2026 revenue $28.5M, GAAP net income $45.1M, adjusted EBITDA $7.4M - TradingView
BioLife Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioLife Solutions (NASDAQ:BLFS) Hits New 52-Week HighStill a Buy? - MarketBeat
BioLife Solutions set to report earnings under takeover cloud By Investing.com - Investing.com Nigeria
Biolife Solutions stock hits 52-week high at 33.18 USD - Investing.com
Biolife Solutions stock hits 52-week high at 33.18 USD By Investing.com - Investing.com South Africa
Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout - stocktitan.net
BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Growth with Precision in the Healthcare Sector - DirectorsTalk Interviews
Repligen to acquire BioLife Solutions in two-step merger; employee video details timeline - TradingView
BioLife Solutions (BLFS) to Post Earnings on Thursday - MarketBeat
Biolife Solutions stock hits 52-week high at 32.24 USD By Investing.com - Investing.com South Africa
Biolife Solutions stock hits 52-week high at 32.24 USD - Investing.com
BioLife Solutions (NASDAQ:BLFS) Sets New 12-Month HighStill a Buy? - MarketBeat
BLFS|BioLife Solutions Inc|Price:29.950|Chg%:-0.030 - TradingKey
BioLife Solutions Inc (BLFS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HC Wainwright Expects Higher Earnings for BioLife Solutions - MarketBeat
BioLife Solutions Inc (BLFS) Income Statement - tradingkey.com
BioLife Solutions Inc (BLFS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BLFS|BioLife Solutions Inc|Price:29.980|Chg%:-0.790 - TradingKey
BioLife Solutions Inc (BLFS) Institutional Confidence - TradingKey
BioLife Solutions Inc (BLFS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioLife Solutions, Inc. Revenue Breakdown – GETTEX:BJX1 - TradingView
BioLife Solutions (NASDAQ:BLFS) Stock Rating Lowered by Wall Street Zen - MarketBeat
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc.BLFS - Business Wire
Repligen Corporation to Acquire BioLife Solutions for $1.5 Billion, Boosting Cell Therapy Market Presence - Kalkine Media
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-and-stock deal - Stock Titan
BIOLIFE SOLUTIONS INC : JEFFERIES CUTS TO HOLD FROM BUY; RAISES TARGET PRICE TO $31 FROM $30 - Bitget
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition - Sahm
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout - TradingView
Jefferies Downgrades BioLife Solutions to Hold From Buy, Adjusts Price Target to $31 From $30 - Moomoo
BioLife Solutions (NASDAQ:BLFS) Sees Strong Trading VolumeWhat's Next? - MarketBeat
BIOLIFE SOLUTIONS INC : TD COWEN CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $31 FROM $33 - Bitget
Bothell firm fetches $1.5 billion in acquisition by Massachusetts company - The Business Journals
Biolife Solutions Inc (BLFS) 財務データ
収益
当期純利益
現金流量
EPS
2.90%
1.18%
大文字化:
|
ボリューム (24 時間):